Francesca Chiodi

Soluble factors released by virus specific activated cytotoxic T-lymphocytes induce apoptotic death of astroglioma cell lines.

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A-D.

The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.

Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.

Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients.

Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection.

FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.

Potential role for IL-7 in Fas-mediated T cell apoptosis during HIV infection.

Relationship between serum IL-7 concentrations and lymphopenia upon different levels of HIV immune control.

Altered distribution of natural killer cell subsets identified by CD56, CD27 and CD70 in primary and chronic human immunodeficiency virus-1 infection.

Chemokine CXCL12 enhances proliferation in pre-B-ALL via STAT5 activation.

B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.

Priming of T cells to Fas-mediated proliferative signals by interleukin-7.

Immunity against HIV/AIDS, malaria, and tuberculosis during co-infections with neglected infectious diseases: recommendations for the European Union research priorities.

Altered expression of the receptor-ligand pair CXCR5/CXCL13 in B cells during chronic HIV-1 infection.

CD27(-) B-cells produce class switched and somatically hyper-mutated antibodies during chronic HIV-1 infection.

Timing of HAART defines the integrity of memory B cells and the longevity of humoral responses in HIV-1 vertically-infected children.

Dysfunctional B-cell responses during HIV-1 infection: implication for influenza vaccination and highly active antiretroviral therapy.

Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

New therapy to revert dysfunctional antibody responses during HIV-1 infection.

Measles outbreak in Africa--is there a link to the HIV-1 epidemic?

Survival and proliferation of CD28- T cells during HIV-1 infection relate to the amplitude of viral replication.

IL-7 promotes CD95-induced apoptosis in B cells via the IFN-γ/STAT1 pathway.

IL-7 modulates B cells survival and activation by inducing BAFF and CD70 expression in T cells.

The impact of inflammation and immune activation on B cell differentiation during HIV-1 infection.

Concerted effect of lymphopenia, viraemia and T-cell activation on Fas expression of peripheral B cells in HIV-1-infected patients.

Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.

Impairment of B-cell functions during HIV-1 infection.

Toll-like receptor 3 signalling up-regulates expression of the HIV co-receptor G-protein coupled receptor 15 on human CD4+ T cells.

B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial.

Frequency and phenotype of B cell subpopulations in young and aged HIV-1 infected patients receiving ART.

Impaired Phenotype and Function of T Follicular Helper Cells in HIV-1-Infected Children Receiving ART.

Increased extrafollicular expression of the B-cell stimulatory molecule CD70 in HIV-1-infected individuals.

Dysfunctions in the migratory phenotype and properties of circulating immature transitional B cells during HIV-1 infection.

Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.

Pneumococcal vaccination of HIV-infected young adults is an important global priority.

Impaired B cells survival upon production of inflammatory cytokines by HIV-1 exposed follicular dendritic cells.

Dendritic Cell Response to HIV-1 Is Controlled by Differentiation Programs in the Cells and Strain-Specific Properties of the Virus.

IL-7 and CD4 T Follicular Helper Cells in HIV-1 Infection.

T follicular helper cells and antibody response to Hepatitis B virus vaccine in HIV-1 infected children receiving ART.

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies.

DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response.

Mass cytometry identifies distinct CD4+ T cell clusters distinguishing HIV-1-infected patients according to antiretroviral therapy initiation.

Homing defects of B cells in HIV-1 infected children impair vaccination responses.

Impact of chemokine C-C ligand 27, foreskin anatomy and sexually transmitted infections on HIV-1 target cell availability in adolescent South African males.

Early Antiretroviral Therapy May Preserve Vaccine Responses in Human Immunodeficiency Virus-Infected Patients by Preventing Damage to Long-Lived Plasma Cells.

Nasopharyngeal Carriage among PCV-10-Vaccinated HIV-1-Infected Children with Maintained Serological Memory in Ethiopia.

Profiling of Inflammatory Proteins in Plasma of HIV-1-Infected Children Receiving Antiretroviral Therapy.

High CD45 expression of CD8+ and CD4+ T cells correlates with the size of HIV-1 reservoir in blood.

Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind.

The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination.

Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth.

Publisher Correction to: Direct contact between Plasmodium falciparum and human B-cells in a novel co-culture increases parasite growth and affects B-cell growth.

Distinct transcriptomic profiles of naïve CD4+ T cells distinguish HIV-1 infected patients initiating antiretroviral therapy at acute or chronic phase of infection.

Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals.

Impaired CD4+ T cell differentiation in HIV-1 infected patients receiving early anti-retroviral therapy.

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.

Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.

Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention.

Proteomic Analysis of Mucosal and Systemic Responses to SARS-CoV-2 Antigen.

A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin.

Dose finding study for on-demand HIV pre-exposure prophylaxis for insertive sex in sub-Saharan Africa: results from the CHAPS open label randomised controlled trial.

Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication.

challenge models for infectious diseases.

Bacterial microbiome and host inflammatory gene expression in foreskin tissue.